Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8895500
APP PUB NO 20130237472A1
SERIAL NO

13822775

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a modified human tumor necrosis factor receptor-1 polypeptide which is capable of binding to a tumor necrosis factor in vivo or ex vivo, or to a fragment thereof. The modified human tumor necrosis factor receptor-1 polypeptide or the fragment thereof according to the present invention exhibit improved binding affinity to the tumor necrosis factor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANALL BIOPHARMA CO LTD400-1 SANGSEO-DONG DAEDEOK-GU DAEJEON 306-120

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jeong, Jae Kap Gyeonggi-do, KR 19 18
Jun, Sung Soo Gyeonggi-do, KR 39 261
Kim, Eun Sun Gyeonggi-do, KR 187 3293
Kim, Ha Na Gyeonggi-do, KR 52 379
Kim, Song Young Gyeonggi-do, KR 4 7
Kim, Sung Wuk Gyeonggi-do, KR 51 282
Park, Seung Kook Seoul, KR 24 20
Song, Yeon Jung Gyeonggi-do, KR 15 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 25, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00